Ira Tabas - Publications

Affiliations: 
Cellular Physiology and Biophysics Columbia University, New York, NY 
Area:
Medicine and Surgery, Physiology Biology

219 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Sukka SR, Ampomah PB, Darville LNF, Ngai D, Wang X, Kuriakose G, Xiao Y, Shi J, Koomen JM, McCusker RH, Tabas I. Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution. Nature Metabolism. PMID 39242914 DOI: 10.1038/s42255-024-01115-7  0.312
2023 Yalcinkaya M, Liu W, Thomas LA, Olszewska M, Xiao T, Abramowicz S, Papapetrou EP, Westerterp M, Wang N, Tabas I, Tall AR. BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in Clonal Hematopoiesis. Circulation. PMID 37781816 DOI: 10.1161/CIRCULATIONAHA.123.065344  0.453
2023 Dai W, Zhang H, Lund H, Zhang Z, Castleberry M, Rodriguez M, Kuriakose G, Gupta S, Lewandowska M, Powers HR, Valmiki S, Zhu J, Shapiro AD, Hussain MM, López JA, ... ... Tabas I, et al. Intracellular tPA-PAI-1 interaction determines VLDL assembly in hepatocytes. Science (New York, N.Y.). 381: eadh5207. PMID 37651538 DOI: 10.1126/science.adh5207  0.302
2023 Liu W, Yalcinkaya M, Maestre IF, Olszewska M, Ampomah PB, Heimlich JB, Wang R, Vela PS, Xiao T, Bick AG, Levine R, Papapetrou EP, Libby P, Tabas I, Wang N, et al. Blockade of IL-6 signaling alleviates atherosclerosis in -deficient clonal hematopoiesis. Nature Cardiovascular Research. 2: 572-586. PMID 37539077 DOI: 10.1038/s44161-023-00281-3  0.427
2023 Schilperoort M, Ngai D, Sukka SR, Avrampou K, Shi H, Tabas I. The role of efferocytosis-fueled macrophage metabolism in the resolution of inflammation. Immunological Reviews. PMID 37158427 DOI: 10.1111/imr.13214  0.31
2023 Schilperoort M, Ngai D, Katerelos M, Power DA, Tabas I. PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages. Nature Metabolism. PMID 36797420 DOI: 10.1038/s42255-023-00736-8  0.334
2022 Ampomah PB, Cai B, Sukka SR, Gerlach BD, Yurdagul A, Wang X, Kuriakose G, Darville LNF, Sun Y, Sidoli S, Koomen JM, Tall AR, Tabas I. Macrophages use apoptotic cell-derived methionine and DNMT3A during efferocytosis to promote tissue resolution. Nature Metabolism. PMID 35361955 DOI: 10.1038/s42255-022-00551-7  0.474
2021 Gerlach BD, Ampomah PB, Yurdagul A, Liu C, Lauring MC, Wang X, Kasikara C, Kong N, Shi J, Tao W, Tabas I. Efferocytosis induces macrophage proliferation to help resolve tissue injury. Cell Metabolism. PMID 34784501 DOI: 10.1016/j.cmet.2021.10.015  0.312
2020 Tao W, Yurdagul A, Kong N, Li W, Wang X, Doran AC, Feng C, Wang J, Islam MA, Farokhzad OC, Tabas I, Shi J. siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice. Science Translational Medicine. 12. PMID 32718990 DOI: 10.1126/Scitranslmed.Aay1063  0.401
2020 Liu L, Fan L, Chan M, Kraakman MJ, Yang J, Fan Y, Aaron N, Wan Q, Carrillo-Sepulveda MA, Tall AR, Tabas I, Accili D, Qiang L. PPARγ Deacetylation Confers the Anti-Atherogenic Effect and Improves Endothelial Function in Diabetes Treatment. Diabetes. PMID 32409492 DOI: 10.2337/Db20-0217  0.53
2020 Tabas I, Bornfeldt KE. Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis. Circulation Research. 126: 1209-1227. PMID 32324504 DOI: 10.1161/Circresaha.119.315939  0.413
2020 Wang X, Cai B, Yang X, Sonubi OO, Zheng Z, Ramakrishnan R, Shi H, Valenti L, Pajvani UB, Sandhu J, Infante RE, Radhakrishnan A, Covey DF, Guan KL, Buck J, ... ... Tabas I, et al. Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis. Cell Metabolism. PMID 32259482 DOI: 10.1016/J.Cmet.2020.03.010  0.427
2020 Schwabe RF, Tabas I, Pajvani UB. Mechanisms of Fibrosis Development in NASH. Gastroenterology. PMID 32044315 DOI: 10.1053/J.Gastro.2019.11.311  0.309
2020 Yurdagul A, Subramanian M, Wang X, Crown SB, Ilkayeva OR, Darville L, Kolluru GK, Rymond CC, Gerlach BD, Zheng Z, Kuriakose G, Kevil CG, Koomen JM, Cleveland JL, Muoio DM, ... Tabas I, et al. Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury. Cell Metabolism. PMID 32004476 DOI: 10.1016/J.Cmet.2020.01.001  0.371
2020 Wang X, Schwabe R, Tabas I. Abstract IA23: The role of hepatocyte TAZ in NASH and NASH-HCC Molecular Cancer Research. 18. DOI: 10.1158/1557-3125.Hippo19-Ia23  0.302
2020 Wang X, Radhakrishnan A, Covey D, Horton J, Schwabe R, Tontonoz P, Guan K, Tabas I. Abstract B04: Hepatic cholesterol upregulates TAZ in nonalcoholic steatohepatitis Molecular Cancer Research. 18. DOI: 10.1158/1557-3125.Hippo19-B04  0.422
2019 Cai B, Dongiovanni P, Corey KE, Wang X, Shmarakov IO, Zheng Z, Kasikara C, Davra V, Meroni M, Chung RT, Rothlin CV, Schwabe RF, Blaner WS, Birge RB, Valenti L, ... Tabas I, et al. Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis. Cell Metabolism. PMID 31839486 DOI: 10.1016/J.Cmet.2019.11.013  0.341
2019 Doran AC, Yurdagul A, Tabas I. Efferocytosis in health and disease. Nature Reviews. Immunology. PMID 31822793 DOI: 10.1038/S41577-019-0240-6  0.327
2019 Liu T, Xiang A, Peng T, Doran AC, Tracey KJ, Barnes BJ, Tabas I, Son M, Diamond B. HMGB1-C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis. Proceedings of the National Academy of Sciences of the United States of America. PMID 31570601 DOI: 10.1073/Pnas.1907490116  0.417
2019 Bäck M, Yurdagul A, Tabas I, Öörni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nature Reviews. Cardiology. PMID 30846875 DOI: 10.1038/S41569-019-0169-2  0.462
2019 Zheng Z, Nakamura K, Gershbaum S, Tabas I. The Markedly Increased PAI1 in Obesity Induces a Compensatory Increase of Hepatocyte Tpa Expression By Activating a LRP1-CREB1 Pathway Blood. 134: 3625-3625. DOI: 10.1182/Blood-2019-129271  0.349
2018 Thomas DG, Doran AC, Fotakis P, Westerterp M, Antonson P, Jiang H, Jiang XC, Gustafsson JÅ, Tabas I, Tall AR. LXR Suppresses Inflammatory Gene Expression and Neutrophil Migration through cis-Repression and Cholesterol Efflux. Cell Reports. 25: 3774-3785.e4. PMID 30590048 DOI: 10.1016/J.Celrep.2018.11.100  0.567
2018 Wang W, Liu W, Fidler T, Wang Y, Tang Y, Woods B, Welch C, Cai B, Silvestre-Roig C, Ai D, Yang YG, Hidalgo A, Soehnlein O, Tabas I, Levine RL, et al. Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2 Mice. Circulation Research. 123: e35-e47. PMID 30571460 DOI: 10.1161/Circresaha.118.313283  0.528
2018 Zheng Z, Nayak L, Wang W, Yurdagul A, Wang X, Cai B, Lapping S, Ozcan L, Ramakrishnan R, Pestell RG, Jain MK, Tabas I. An ATF6-tPA pathway in hepatocytes contributes to systemic fibrinolysis and is repressed by DACH1. Blood. PMID 30504459 DOI: 10.1182/Blood-2018-07-864843  0.331
2018 Zhu C, Kim K, Wang X, Bartolome A, Salomao M, Dongiovanni P, Meroni M, Graham MJ, Yates KP, Diehl AM, Schwabe RF, Tabas I, Valenti L, Lavine JE, Pajvani UB. Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis. Science Translational Medicine. 10. PMID 30463916 DOI: 10.1126/Scitranslmed.Aat0344  0.309
2018 Robinson JG, Williams KJ, Gidding S, Borén J, Tabas I, Fisher EA, Packard C, Pencina M, Fayad ZA, Mani V, Rye KA, Nordestgaard BG, Tybjærg-Hansen A, Douglas PS, Nicholls SJ, et al. Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life. Journal of the American Heart Association. 7: e009778. PMID 30371276 DOI: 10.1161/Jaha.118.009778  0.337
2018 Moore KJ, Koplev S, Fisher EA, Tabas I, Björkegren JLM, Doran AC, Kovacic JC. Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis: JACC Macrophage in CVD Series (Part 2). Journal of the American College of Cardiology. 72: 2181-2197. PMID 30360827 DOI: 10.1016/J.Jacc.2018.08.2147  0.43
2018 Proto JD, Doran AC, Gusarova G, Yurdagul A, Sozen E, Subramanian M, Islam MN, Rymond CC, Du J, Hook J, Kuriakose G, Bhattacharya J, Tabas I. Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution. Immunity. PMID 30291029 DOI: 10.1016/J.Immuni.2018.07.015  0.371
2018 Cai B, Kasikara C, Doran AC, Ramakrishnan R, Birge RB, Tabas I. MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity. Science Signaling. 11. PMID 30254055 DOI: 10.1126/Scisignal.Aar3721  0.392
2018 Ozcan L, Tabas I. A New Activator of Hepatocyte CaMKII in Fasting and Type 2 Diabetes. Diabetes. 67: 1742-1744. PMID 30135135 DOI: 10.2337/Dbi18-0026  0.317
2018 Kasikara C, Doran AC, Cai B, Tabas I. The role of non-resolving inflammation in atherosclerosis. The Journal of Clinical Investigation. 128: 2713-2723. PMID 30108191 DOI: 10.1172/Jci97950  0.423
2018 Proto JD, Doran AC, Subramanian M, Wang H, Zhang M, Sozen E, Rymond CC, Kuriakose G, D'Agati V, Winchester R, Sykes M, Yang YG, Tabas I. Hypercholesterolemia induces T cell expansion in humanized immune mice. The Journal of Clinical Investigation. PMID 29708512 DOI: 10.1172/Jci97785  0.393
2018 Ghorpade DS, Ozcan L, Zheng Z, Nicoloro SM, Shen Y, Chen E, Blüher M, Czech MP, Tabas I. Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance. Nature. PMID 29562231 DOI: 10.1038/Nature26138  0.303
2018 Zheng Z, Nayak LV, Jain M, Tabas I. Hepatocyte-Derived Tissue Plasminogen Activator Regulates Systemic Fibrinolysis Blood. 132: 217-217. DOI: 10.1182/Blood-2018-99-119362  0.341
2018 Wang W, Liu W, Wang Y, Tang Y, Woods B, Welch C, Cai B, Ai D, Yang Y, Silvestre C, Soehnlein O, Tabas I, Levine RL, Tall AR, Wang N. Abstract 040: Accelerated Atherosclerosis and Thrombosis in Jak2v617f Mice Arteriosclerosis, Thrombosis, and Vascular Biology. 38. DOI: 10.1161/Atvb.38.Suppl_1.040  0.479
2017 Yurdagul A, Doran AC, Cai B, Fredman G, Tabas IA. Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis. Frontiers in Cardiovascular Medicine. 4: 86. PMID 29379788 DOI: 10.3389/Fcvm.2017.00086  0.333
2017 Tabas I, Lichtman AH. Monocyte-Macrophages and T Cells in Atherosclerosis. Immunity. 47: 621-634. PMID 29045897 DOI: 10.1016/J.Immuni.2017.09.008  0.375
2017 Doran AC, Ozcan L, Cai B, Zheng Z, Fredman G, Rymond CC, Dorweiler B, Sluimer JC, Hsieh J, Kuriakose G, Tall AR, Tabas I. CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis. The Journal of Clinical Investigation. PMID 28972541 DOI: 10.1172/Jci94735  0.609
2017 DeBerge M, Yeap XY, Dehn S, Zhang S, Grigoryeva LS, Misener S, Procissi D, Zhou X, Lee DC, Muller WA, Luo X, Rothlin C, Tabas I, Thorp EB. MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair after Myocardial Ischemia Reperfusion Injury. Circulation Research. PMID 28851810 DOI: 10.1161/Circresaha.117.311327  0.305
2017 Wang Y, Wang W, Wang N, Tall AR, Tabas I. Mitochondrial Oxidative Stress Promotes Atherosclerosis and Neutrophil Extracellular Traps in Aged Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 28596373 DOI: 10.1161/Atvbaha.117.309580  0.495
2017 Fredman G, Tabas I. Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy. The American Journal of Pathology. 187: 1211-1221. PMID 28527709 DOI: 10.1016/J.Ajpath.2017.01.018  0.355
2017 Ouimet M, Ediriweera H, Afonso MS, Ramkhelawon B, Singaravelu R, Liao X, Bandler RC, Rahman K, Fisher EA, Rayner KJ, Pezacki JP, Tabas I, Moore KJ. microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 28428217 DOI: 10.1161/Atvbaha.116.308916  0.369
2017 Cai B, Thorp EB, Doran AC, Sansbury BE, Daemen MJ, Dorweiler B, Spite M, Fredman G, Tabas I. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis. The Journal of Clinical Investigation. PMID 28067670 DOI: 10.1172/Jci90520  0.464
2016 Wang X, Zheng Z, Caviglia JM, Corey KE, Herfel TM, Cai B, Masia R, Chung RT, Lefkowitch JH, Schwabe RF, Tabas I. Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis. Cell Metabolism. 24: 848-862. PMID 28068223 DOI: 10.1016/J.Cmet.2016.09.016  0.312
2016 Tabas I. 2016 Russell Ross Memorial Lecture in Vascular Biology: Molecular-Cellular Mechanisms in the Progression of Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 27979856 DOI: 10.1161/Atvbaha.116.308036  0.413
2016 Ozcan L, Tabas I. Calcium signalling and ER stress in insulin resistance and atherosclerosis. Journal of Internal Medicine. PMID 27739133 DOI: 10.1111/Joim.12562  0.302
2016 Fredman G, Hellmann J, Proto JD, Kuriakose G, Colas RA, Dorweiler B, Connolly ES, Solomon R, Jones DM, Heyer EJ, Spite M, Tabas I. An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques. Nature Communications. 7: 12859. PMID 27659679 DOI: 10.1038/Ncomms12859  0.433
2016 Tabas I. Heart disease: Death-defying plaque cells. Nature. PMID 27437578 DOI: 10.1038/Nature18916  0.352
2016 Ozcan L, Ghorpade DS, Zheng Z, de Souza JC, Chen K, Bessler M, Bagloo M, Schrope B, Pestell R, Tabas I. Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin Resistance. Cell Reports. PMID 27239042 DOI: 10.1016/J.Celrep.2016.05.006  0.307
2016 Cai B, Thorp EB, Doran AC, Subramanian M, Sansbury BE, Lin CS, Spite M, Fredman G, Tabas I. MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation. Proceedings of the National Academy of Sciences of the United States of America. PMID 27199481 DOI: 10.1073/Pnas.1524292113  0.376
2015 Williams KJ, Tabas I, Fisher EA. How an Artery Heals. Circulation Research. 117: 909-13. PMID 26541678 DOI: 10.1161/Circresaha.115.307609  0.439
2015 Subramanian M, Ozcan L, Ghorpade DS, Ferrante AW, Tabas I. Suppression of Adaptive Immune Cell Activation Does Not Alter Innate Immune Adipose Inflammation or Insulin Resistance in Obesity. Plos One. 10: e0135842. PMID 26317499 DOI: 10.1371/Journal.Pone.0135842  0.346
2015 Hansson GK, Libby P, Tabas I. Inflammation and plaque vulnerability. Journal of Internal Medicine. PMID 26260307 DOI: 10.1111/Joim.12406  0.32
2015 Zhou AX, Wang X, Lin CS, Han J, Yong J, Nadolski MJ, Borén J, Kaufman RJ, Tabas I. C/EBP-Homologous Protein (CHOP) in Vascular Smooth Muscle Cells Regulates Their Proliferation in Aortic Explants and Atherosclerotic Lesions. Circulation Research. 116: 1736-43. PMID 25872946 DOI: 10.1161/Circresaha.116.305602  0.34
2015 Tabas I, García-Cardeña G, Owens GK. Recent insights into the cellular biology of atherosclerosis. The Journal of Cell Biology. 209: 13-22. PMID 25869663 DOI: 10.1083/Jcb.201412052  0.386
2015 Fredman G, Kamaly N, Spolitu S, Milton J, Ghorpade D, Chiasson R, Kuriakose G, Perretti M, Farokhzad O, Farokzhad O, Tabas I. Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Science Translational Medicine. 7: 275ra20. PMID 25695999 DOI: 10.1126/Scitranslmed.Aaa1065  0.373
2015 Daugherty A, Tabas I, Rader DJ. Accelerating the pace of atherosclerosis research. Arteriosclerosis, Thrombosis, and Vascular Biology. 35: 11-2. PMID 25520521 DOI: 10.1161/Atvbaha.114.304833  0.407
2015 Subramanian M, Thorp E, Tabas I. Identification of a non-growth factor role for GM-CSF in advanced atherosclerosis: promotion of macrophage apoptosis and plaque necrosis through IL-23 signaling. Circulation Research. 116: e13-24. PMID 25348165 DOI: 10.1161/Circresaha.116.304794  0.363
2014 Fredman G, Ozcan L, Spolitu S, Hellmann J, Spite M, Backs J, Tabas I. Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway. Proceedings of the National Academy of Sciences of the United States of America. 111: 14530-5. PMID 25246560 DOI: 10.1073/Pnas.1410851111  0.335
2014 Wang Y, Tabas I. Emerging roles of mitochondria ROS in atherosclerotic lesions: causation or association? Journal of Atherosclerosis and Thrombosis. 21: 381-90. PMID 24717761 DOI: 10.5551/Jat.23929  0.332
2014 Wang M, Subramanian M, Abramowicz S, Murphy AJ, Gonen A, Witztum J, Welch C, Tabas I, Westerterp M, Tall AR. Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency. Arteriosclerosis, Thrombosis, and Vascular Biology. 34: 976-84. PMID 24651678 DOI: 10.1161/Atvbaha.113.303097  0.568
2014 Subramanian M, Hayes CD, Thome JJ, Thorp E, Matsushima GK, Herz J, Farber DL, Liu K, Lakshmana M, Tabas I. An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo. The Journal of Clinical Investigation. 124: 1296-308. PMID 24509082 DOI: 10.1172/Jci72051  0.31
2014 Wang Y, Wang GZ, Rabinovitch PS, Tabas I. Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB-mediated inflammation in macrophages. Circulation Research. 114: 421-33. PMID 24297735 DOI: 10.1161/Circresaha.114.302153  0.341
2014 Subramanian M, Tabas I. Dendritic cells in atherosclerosis. Seminars in Immunopathology. 36: 93-102. PMID 24196454 DOI: 10.1007/S00281-013-0400-X  0.34
2013 Ozcan L, Cristina de Souza J, Harari AA, Backs J, Olson EN, Tabas I. Activation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling. Cell Metabolism. 18: 803-15. PMID 24268736 DOI: 10.1016/J.Cmet.2013.10.011  0.3
2013 Tabas I. Making things stick in the fight against atherosclerosis. Circulation Research. 112: 1094-6. PMID 23580771 DOI: 10.1161/Circresaha.113.301227  0.369
2013 Zhou AX, Tabas I. The UPR in atherosclerosis. Seminars in Immunopathology. 35: 321-32. PMID 23553213 DOI: 10.1007/S00281-013-0372-X  0.406
2013 Tabas I, Glass CK. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science (New York, N.Y.). 339: 166-72. PMID 23307734 DOI: 10.1126/Science.1230720  0.303
2013 Subramanian M, Thorp E, Hansson GK, Tabas I. Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs. The Journal of Clinical Investigation. 123: 179-88. PMID 23257360 DOI: 10.1172/Jci64617  0.37
2013 Rong JX, Blachford C, Feig JE, Bander I, Mayne J, Kusunoki J, Miller C, Davis M, Wilson M, Dehn S, Thorp E, Tabas I, Taubman MB, Rudel LL, Fisher EA. ACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 4-12. PMID 23139293 DOI: 10.1161/Atvbaha.112.252056  0.446
2013 Richards MR, Black AS, Bonnet DJ, Barish GD, Woo CW, Tabas I, Curtiss LK, Tobias PS. The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice. Innate Immunity. 19: 20-9. PMID 22637968 DOI: 10.1177/1753425912447130  0.41
2012 Tabas I. Cardiology: Bad matters made worse. Nature. 487: 306-8. PMID 22810692 DOI: 10.1038/487306A  0.318
2012 Liang CP, Han S, Li G, Tabas I, Tall AR. Impaired MEK signaling and SERCA expression promote ER stress and apoptosis in insulin-resistant macrophages and are reversed by exenatide treatment. Diabetes. 61: 2609-20. PMID 22751695 DOI: 10.2337/Db11-1415  0.565
2012 Ai D, Baez JM, Jiang H, Conlon DM, Hernandez-Ono A, Frank-Kamenetsky M, Milstein S, Fitzgerald K, Murphy AJ, Woo CW, Strong A, Ginsberg HN, Tabas I, Rader DJ, Tall AR. Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice. The Journal of Clinical Investigation. 122: 1677-87. PMID 22466652 DOI: 10.1172/Jci61248  0.531
2012 Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, Robbins J, Martinez J, Tabas I. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metabolism. 15: 545-53. PMID 22445600 DOI: 10.1016/J.Cmet.2012.01.022  0.418
2012 Tsuchiya K, Tanaka J, Shuiqing Y, Welch CL, DePinho RA, Tabas I, Tall AR, Goldberg IJ, Accili D. FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis. Cell Metabolism. 15: 372-81. PMID 22405072 DOI: 10.1016/J.Cmet.2012.01.018  0.546
2012 Woo CW, Kutzler L, Kimball SR, Tabas I. Toll-like receptor activation suppresses ER stress factor CHOP and translation inhibition through activation of eIF2B. Nature Cell Biology. 14: 192-200. PMID 22231169 DOI: 10.1038/Ncb2408  0.348
2011 Scull CM, Tabas I. Mechanisms of ER stress-induced apoptosis in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 2792-7. PMID 22096099 DOI: 10.1161/Atvbaha.111.224881  0.347
2011 Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metabolism. 14: 575-85. PMID 22055501 DOI: 10.1016/J.Cmet.2011.07.015  0.304
2011 Thorp E, Subramanian M, Tabas I. The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis. European Journal of Immunology. 41: 2515-8. PMID 21952808 DOI: 10.1002/Eji.201141719  0.416
2011 Tsuchiya K, Banks AS, Liang CP, Tabas I, Tall AR, Accili D. Homozygosity for an allele encoding deacetylated FoxO1 protects macrophages from cholesterol-induced inflammation without increasing apoptosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 2920-8. PMID 21940942 DOI: 10.1161/Atvbaha.110.219477  0.584
2011 Thorp E, Vaisar T, Subramanian M, Mautner L, Blobel C, Tabas I. Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cδ, and p38 mitogen-activated protein kinase (MAPK). The Journal of Biological Chemistry. 286: 33335-44. PMID 21828049 DOI: 10.1074/Jbc.M111.263020  0.376
2011 Ouimet M, Franklin V, Mak E, Liao X, Tabas I, Marcel YL. Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell Metabolism. 13: 655-67. PMID 21641547 DOI: 10.1016/J.Cmet.2011.03.023  0.494
2011 Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 145: 341-55. PMID 21529710 DOI: 10.1016/J.Cell.2011.04.005  0.414
2011 Thorp E, Iwawaki T, Miura M, Tabas I. A reporter for tracking the UPR in vivo reveals patterns of temporal and cellular stress during atherosclerotic progression. Journal of Lipid Research. 52: 1033-8. PMID 21357531 DOI: 10.1194/Jlr.D012492  0.385
2011 Shechtman CF, Henneberry AL, Seimon TA, Tinkelenberg AH, Wilcox LJ, Lee E, Fazlollahi M, Munkacsi AB, Bussemaker HJ, Tabas I, Sturley SL. Loss of subcellular lipid transport due to ARV1 deficiency disrupts organelle homeostasis and activates the unfolded protein response. The Journal of Biological Chemistry. 286: 11951-9. PMID 21266578 DOI: 10.1074/Jbc.M110.215038  0.383
2010 Seimon TA, Nadolski MJ, Liao X, Magallon J, Nguyen M, Feric NT, Koschinsky ML, Harkewicz R, Witztum JL, Tsimikas S, Golenbock D, Moore KJ, Tabas I. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metabolism. 12: 467-82. PMID 21035758 DOI: 10.1016/J.Cmet.2010.09.010  0.442
2010 Tabas I. The role of endoplasmic reticulum stress in the progression of atherosclerosis. Circulation Research. 107: 839-50. PMID 20884885 DOI: 10.1161/Circresaha.110.224766  0.397
2010 Seimon TA, Kim MJ, Blumenthal A, Koo J, Ehrt S, Wainwright H, Bekker LG, Kaplan G, Nathan C, Tabas I, Russell DG. Induction of ER stress in macrophages of tuberculosis granulomas. Plos One. 5: e12772. PMID 20856677 DOI: 10.1371/Journal.Pone.0012772  0.365
2010 Yvan-Charvet L, Pagler TA, Seimon TA, Thorp E, Welch CL, Witztum JL, Tabas I, Tall AR. ABCA1 and ABCG1 protect against oxidative stress-induced macrophage apoptosis during efferocytosis. Circulation Research. 106: 1861-9. PMID 20431058 DOI: 10.1161/Circresaha.110.217281  0.614
2010 Chandak PG, Radovic B, Aflaki E, Kolb D, Buchebner M, Fröhlich E, Magnes C, Sinner F, Haemmerle G, Zechner R, Tabas I, Levak-Frank S, Kratky D. Efficient phagocytosis requires triacylglycerol hydrolysis by adipose triglyceride lipase. The Journal of Biological Chemistry. 285: 20192-201. PMID 20424161 DOI: 10.1074/Jbc.M110.107854  0.436
2010 Devlin C, Pipalia NH, Liao X, Schuchman EH, Maxfield FR, Tabas I. Improvement in lipid and protein trafficking in Niemann-Pick C1 cells by correction of a secondary enzyme defect. Traffic (Copenhagen, Denmark). 11: 601-15. PMID 20412078 DOI: 10.1111/J.1600-0854.2010.01046.X  0.402
2010 Nawrocki AR, Hofmann SM, Teupser D, Basford JE, Durand JL, Jelicks LA, Woo CW, Kuriakose G, Factor SM, Tanowitz HB, Hui DY, Tabas I, Scherer PE. Lack of association between adiponectin levels and atherosclerosis in mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 1159-65. PMID 20299691 DOI: 10.1161/Atvbaha.109.195826  0.414
2010 Tabas I, Tall A, Accili D. The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression. Circulation Research. 106: 58-67. PMID 20056946 DOI: 10.1161/Circresaha.109.208488  0.538
2010 Ozcan L, Tabas I. Pivotal role of calcium/calmodulin-dependent protein kinase II in ER stress-induced apoptosis. Cell Cycle (Georgetown, Tex.). 9: 223-4. PMID 20023415 DOI: 10.4161/Cc.9.2.10596  0.35
2010 Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nature Reviews. Immunology. 10: 36-46. PMID 19960040 DOI: 10.1038/Nri2675  0.427
2009 Woo CW, Cui D, Arellano J, Dorweiler B, Harding H, Fitzgerald KA, Ron D, Tabas I. Adaptive suppression of the ATF4-CHOP branch of the unfolded protein response by toll-like receptor signalling. Nature Cell Biology. 11: 1473-80. PMID 19855386 DOI: 10.1038/Ncb1996  0.357
2009 Li S, Sun Y, Liang CP, Thorp EB, Han S, Jehle AW, Saraswathi V, Pridgen B, Kanter JE, Li R, Welch CL, Hasty AH, Bornfeldt KE, Breslow JL, Tabas I, et al. Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet. Circulation Research. 105: 1072-82. PMID 19834009 DOI: 10.1161/Circresaha.109.199570  0.682
2009 Tabas I, Seimon T, Timmins J, Li G, Lim W. Macrophage apoptosis in advanced atherosclerosis. Annals of the New York Academy of Sciences. 1173: E40-5. PMID 19751413 DOI: 10.1111/J.1749-6632.2009.04957.X  0.424
2009 Timmins JM, Ozcan L, Seimon TA, Li G, Malagelada C, Backs J, Backs T, Bassel-Duby R, Olson EN, Anderson ME, Tabas I. Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways. The Journal of Clinical Investigation. 119: 2925-41. PMID 19741297 DOI: 10.1172/Jci38857  0.32
2009 Thorp E, Tabas I. Differential effects of pioglitazone on advanced atherosclerotic lesions. The American Journal of Pathology. 175: 1348. PMID 19661438 DOI: 10.2353/Ajpath.2009.090483  0.34
2009 Thorp E, Li G, Seimon TA, Kuriakose G, Ron D, Tabas I. Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP. Cell Metabolism. 9: 474-81. PMID 19416717 DOI: 10.1016/J.Cmet.2009.03.003  0.411
2009 Thorp E, Tabas I. Mechanisms and consequences of efferocytosis in advanced atherosclerosis. Journal of Leukocyte Biology. 86: 1089-95. PMID 19414539 DOI: 10.1189/Jlb.0209115  0.418
2009 Seimon TA, Wang Y, Han S, Senokuchi T, Schrijvers DM, Kuriakose G, Tall AR, Tabas IA. Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. The Journal of Clinical Investigation. 119: 886-98. PMID 19287091 DOI: 10.1172/JCI37262  0.531
2009 Tabas I. Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress. Antioxidants & Redox Signaling. 11: 2333-9. PMID 19243235 DOI: 10.1089/Ars.2009.2469  0.456
2009 Sun Y, Ishibashi M, Seimon T, Lee M, Sharma SM, Fitzgerald KA, Samokhin AO, Wang Y, Sayers S, Aikawa M, Jerome WG, Ostrowski MC, Bromme D, Libby P, Tabas IA, et al. Free cholesterol accumulation in macrophage membranes activates Toll-like receptors and p38 mitogen-activated protein kinase and induces cathepsin K. Circulation Research. 104: 455-65. PMID 19122179 DOI: 10.1161/Circresaha.108.182568  0.541
2009 Thorp E, Li Y, Bao L, Yao PM, Kuriakose G, Rong J, Fisher EA, Tabas I. Brief report: increased apoptosis in advanced atherosclerotic lesions of Apoe-/- mice lacking macrophage Bcl-2. Arteriosclerosis, Thrombosis, and Vascular Biology. 29: 169-72. PMID 18988889 DOI: 10.1161/Atvbaha.108.176495  0.434
2009 Seimon T, Tabas I. Mechanisms and consequences of macrophage apoptosis in atherosclerosis. Journal of Lipid Research. 50: S382-7. PMID 18953058 DOI: 10.1194/Jlr.R800032-Jlr200  0.433
2009 Manning-Tobin JJ, Moore KJ, Seimon TA, Bell SA, Sharuk M, Alvarez-Leite JI, de Winther MP, Tabas I, Freeman MW. Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 29: 19-26. PMID 18948635 DOI: 10.1161/Atvbaha.108.176644  0.394
2008 Li Y, Zhang Y, Dorweiler B, Cui D, Wang T, Woo CW, Brunkan CS, Wolberger C, Imai S, Tabas I. Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism. The Journal of Biological Chemistry. 283: 34833-43. PMID 18945671 DOI: 10.1074/Jbc.M805866200  0.372
2008 Packard RR, Maganto-García E, Gotsman I, Tabas I, Libby P, Lichtman AH. CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis. Circulation Research. 103: 965-73. PMID 18832748 DOI: 10.1161/Circresaha.108.185793  0.314
2008 Senokuchi T, Liang CP, Seimon TA, Han S, Matsumoto M, Banks AS, Paik JH, DePinho RA, Accili D, Tabas I, Tall AR. Forkhead transcription factors (FoxOs) promote apoptosis of insulin-resistant macrophages during cholesterol-induced endoplasmic reticulum stress. Diabetes. 57: 2967-76. PMID 18728232 DOI: 10.2337/Db08-0520  0.567
2008 Devlin CM, Leventhal AR, Kuriakose G, Schuchman EH, Williams KJ, Tabas I. Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 1723-30. PMID 18669882 DOI: 10.1161/Atvbaha.108.173344  0.74
2008 Iqbal J, Dai K, Seimon T, Jungreis R, Oyadomari M, Kuriakose G, Ron D, Tabas I, Hussain MM. IRE1beta inhibits chylomicron production by selectively degrading MTP mRNA. Cell Metabolism. 7: 445-55. PMID 18460335 DOI: 10.1016/J.Cmet.2008.03.005  0.389
2008 Thorp E, Cui D, Schrijvers DM, Kuriakose G, Tabas I. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 1421-8. PMID 18451332 DOI: 10.1161/Atvbaha.108.167197  0.43
2008 Lim WS, Timmins JM, Seimon TA, Sadler A, Kolodgie FD, Virmani R, Tabas I. Signal transducer and activator of transcription-1 is critical for apoptosis in macrophages subjected to endoplasmic reticulum stress in vitro and in advanced atherosclerotic lesions in vivo. Circulation. 117: 940-51. PMID 18227389 DOI: 10.1161/Circulationaha.107.711275  0.405
2007 Tabas I, Seimon T, Arellano J, Li Y, Forcheron F, Cui D, Han S, Liang CP, Tall A, Accili D. The impact of insulin resistance on macrophage death pathways in advanced atherosclerosis. Novartis Foundation Symposium. 286: 99-109; discussion 1. PMID 18269177 DOI: 10.1002/9780470985571.Ch9  0.588
2007 Tabas I. Apoptosis and efferocytosis in mouse models of atherosclerosis. Current Drug Targets. 8: 1288-96. PMID 18220705 DOI: 10.2174/138945007783220623  0.413
2007 Thorp E, Kuriakose G, Shah YM, Gonzalez FJ, Tabas I. Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of nondiabetic low-density lipoprotein receptor-null mice. Circulation. 116: 2182-90. PMID 17967777 DOI: 10.1161/Circulationaha.107.698852  0.407
2007 Tabas I, Williams KJ, Borén J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation. 116: 1832-44. PMID 17938300 DOI: 10.1161/Circulationaha.106.676890  0.438
2007 Bao S, Li Y, Lei X, Wohltmann M, Jin W, Bohrer A, Semenkovich CF, Ramanadham S, Tabas I, Turk J. Attenuated free cholesterol loading-induced apoptosis but preserved phospholipid composition of peritoneal macrophages from mice that do not express group VIA phospholipase A2. The Journal of Biological Chemistry. 282: 27100-14. PMID 17627946 DOI: 10.1074/Jbc.M701316200  0.387
2007 Cui D, Thorp E, Li Y, Wang N, Yvan-Charvet L, Tall AR, Tabas I. Pivotal advance: macrophages become resistant to cholesterol-induced death after phagocytosis of apoptotic cells. Journal of Leukocyte Biology. 82: 1040-50. PMID 17576822 DOI: 10.1189/Jlb.0307192  0.627
2007 Tabas I. A two-carbon switch to sterol-induced autophagic death. Autophagy. 3: 38-41. PMID 17172803 DOI: 10.4161/Auto.3398  0.448
2007 Li Y, Tabas I. The inflammatory cytokine response of cholesterol-enriched macrophages is dampened by stimulated pinocytosis. Journal of Leukocyte Biology. 81: 483-91. PMID 17062603 DOI: 10.1189/Jlb.0806518  0.415
2006 Seimon TA, Obstfeld A, Moore KJ, Golenbock DT, Tabas I. Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages. Proceedings of the National Academy of Sciences of the United States of America. 103: 19794-9. PMID 17167049 DOI: 10.1073/Pnas.0609671104  0.404
2006 Bao L, Li Y, Deng SX, Landry D, Tabas I. Sitosterol-containing lipoproteins trigger free sterol-induced caspase-independent death in ACAT-competent macrophages. The Journal of Biological Chemistry. 281: 33635-49. PMID 16935859 DOI: 10.1074/Jbc.M606339200  0.441
2006 Nelson JC, Jiang XC, Tabas I, Tall A, Shea S. Plasma sphingomyelin and subclinical atherosclerosis: findings from the multi-ethnic study of atherosclerosis. American Journal of Epidemiology. 163: 903-12. PMID 16611667 DOI: 10.1093/Aje/Kwj140  0.486
2006 Han S, Liang CP, DeVries-Seimon T, Ranalletta M, Welch CL, Collins-Fletcher K, Accili D, Tabas I, Tall AR. Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metabolism. 3: 257-66. PMID 16581003 DOI: 10.1016/J.Cmet.2006.02.008  0.581
2006 Gerbod-Giannone MC, Li Y, Holleboom A, Han S, Hsu LC, Tabas I, Tall AR. TNFalpha induces ABCA1 through NF-kappaB in macrophages and in phagocytes ingesting apoptotic cells. Proceedings of the National Academy of Sciences of the United States of America. 103: 3112-7. PMID 16492740 DOI: 10.1073/Pnas.0510345103  0.635
2006 Boullier A, Li Y, Quehenberger O, Palinski W, Tabas I, Witztum JL, Miller YI. Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 1169-76. PMID 16484596 DOI: 10.1161/01.Atv.0000210279.97308.9A  0.376
2006 Li Y, Gerbod-Giannone MC, Seitz H, Cui D, Thorp E, Tall AR, Matsushima GK, Tabas I. Cholesterol-induced apoptotic macrophages elicit an inflammatory response in phagocytes, which is partially attenuated by the Mer receptor. The Journal of Biological Chemistry. 281: 6707-17. PMID 16380374 DOI: 10.1074/Jbc.M510579200  0.582
2005 Maxfield FR, Tabas I. Role of cholesterol and lipid organization in disease. Nature. 438: 612-21. PMID 16319881 DOI: 10.1038/Nature04399  0.34
2005 Devries-Seimon T, Li Y, Yao PM, Stone E, Wang Y, Davis RJ, Flavell R, Tabas I. Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor. The Journal of Cell Biology. 171: 61-73. PMID 16203857 DOI: 10.1083/Jcb.200502078  0.443
2005 Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 2255-64. PMID 16141399 DOI: 10.1161/01.Atv.0000184783.04864.9F  0.402
2005 Williams KJ, Tabas I. Lipoprotein retention--and clues for atheroma regression. Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 1536-40. PMID 16055756 DOI: 10.1161/01.Atv.0000174795.62387.D3  0.434
2005 Jacobs RL, Stead LM, Devlin C, Tabas I, Brosnan ME, Brosnan JT, Vance DE. Physiological regulation of phospholipid methylation alters plasma homocysteine in mice. The Journal of Biological Chemistry. 280: 28299-305. PMID 15958390 DOI: 10.1074/Jbc.M501971200  0.316
2005 Devlin CM, Lee SJ, Kuriakose G, Spencer C, Becker L, Grosskopf I, Ko C, Huang LS, Koschinsky ML, Cooper AD, Tabas I. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 1704-10. PMID 15905467 DOI: 10.1161/01.Atv.0000170819.57945.03  0.413
2005 Li Y, Schwabe RF, DeVries-Seimon T, Yao PM, Gerbod-Giannone MC, Tall AR, Davis RJ, Flavell R, Brenner DA, Tabas I. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis. The Journal of Biological Chemistry. 280: 21763-72. PMID 15826936 DOI: 10.1074/Jbc.M501759200  0.545
2005 Wüstner D, Mondal M, Tabas I, Maxfield FR. Direct observation of rapid internalization and intracellular transport of sterol by macrophage foam cells. Traffic (Copenhagen, Denmark). 6: 396-412. PMID 15813750 DOI: 10.1111/J.1600-0854.2005.00285.X  0.385
2005 Baez JM, Tabas I, Cohen DE. Decreased lipid efflux and increased susceptibility to cholesterol-induced apoptosis in macrophages lacking phosphatidylcholine transfer protein. The Biochemical Journal. 388: 57-63. PMID 15628972 DOI: 10.1042/Bj20041899  0.495
2004 Tabas I. Sphingolipids and atherosclerosis: a mechanistic connection? A therapeutic opportunity? Circulation. 110: 3400-1. PMID 15569847 DOI: 10.1161/01.Cir.0000150861.98087.56  0.399
2004 Jacobs RL, Devlin C, Tabas I, Vance DE. Targeted deletion of hepatic CTP:phosphocholine cytidylyltransferase alpha in mice decreases plasma high density and very low density lipoproteins. The Journal of Biological Chemistry. 279: 47402-10. PMID 15331603 DOI: 10.1074/Jbc.M404027200  0.395
2004 Li Y, Ge M, Ciani L, Kuriakose G, Westover EJ, Dura M, Covey DF, Freed JH, Maxfield FR, Lytton J, Tabas I. Enrichment of endoplasmic reticulum with cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2b activity in parallel with increased order of membrane lipids: implications for depletion of endoplasmic reticulum calcium stores and apoptosis in cholesterol-loaded macrophages. The Journal of Biological Chemistry. 279: 37030-9. PMID 15215242 DOI: 10.1074/Jbc.M405195200  0.394
2004 Tabas I. Apoptosis and plaque destabilization in atherosclerosis: The role of macrophage apoptosis induced by cholesterol Cell Death and Differentiation. 11. PMID 15143347 DOI: 10.1038/sj.cdd.4401444  0.361
2004 Liang CP, Han S, Okamoto H, Carnemolla R, Tabas I, Accili D, Tall AR. Increased CD36 protein as a response to defective insulin signaling in macrophages. The Journal of Clinical Investigation. 113: 764-73. PMID 14991075 DOI: 10.1172/Jci19528  0.526
2004 Leventhal AR, Leslie CC, Tabas I. Suppression of macrophage eicosanoid synthesis by atherogenic lipoproteins is profoundly affected by cholesterol-fatty acyl esterification and the Niemann-Pick C pathway of lipid trafficking. The Journal of Biological Chemistry. 279: 8084-92. PMID 14638686 DOI: 10.1074/Jbc.M310672200  0.772
2004 Tabas I. Signal transduction pathways in free cholesterol-loaded macrophages: cell biological insight into the progression of atherosclerosis International Congress Series. 1262: 392-395. DOI: 10.1016/j.ics.2003.12.095  0.305
2003 Feng B, Zhang D, Kuriakose G, Devlin CM, Kockx M, Tabas I. Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America. 100: 10423-8. PMID 12923293 DOI: 10.1073/Pnas.1732494100  0.475
2003 Feng B, Yao PM, Li Y, Devlin CM, Zhang D, Harding HP, Sweeney M, Rong JX, Kuriakose G, Fisher EA, Marks AR, Ron D, Tabas I. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nature Cell Biology. 5: 781-92. PMID 12907943 DOI: 10.1038/Ncb1035  0.477
2003 Feng B, Yao P, Li Y, Devlin C, Zhang D, Harding H, Sweeney M, Rong J, Kuriakose G, Fisher E, Marks A, Ron D, Tabas I. 2WS11-1 Signal transduction pathways in free cholesterol-loaded macrophages: Cell biological insight into the progression of atherosclerosis Atherosclerosis Supplements. 4: 99. DOI: 10.1016/S1567-5688(03)90425-9  0.305
2002 Tabas I. Consequences of cellular cholesterol accumulation: Basic concepts and physiological implications Journal of Clinical Investigation. 110: 905-911. PMID 12370266 DOI: 10.1172/Jci16452  0.474
2002 Feng B, Tabas I. ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages: Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity Journal of Biological Chemistry. 277: 43271-43280. PMID 12215451 DOI: 10.1074/Jbc.M207532200  0.495
2002 Tabas I. Cholesterol in health and disease Journal of Clinical Investigation. 110: 583-590. PMID 12208856 DOI: 10.1172/Jci16381  0.385
2002 Williams KJ, Tabas I. Atherosclerosis and inflammation [4] Science. 297: 521-522. PMID 12143880 DOI: 10.1126/Science.297.5581.521  0.37
2002 Devlin CM, Kuriakose G, Hirsch E, Tabas I. Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size Proceedings of the National Academy of Sciences of the United States of America. 99: 6280-6285. PMID 11983917 DOI: 10.1073/Pnas.092324399  0.355
2002 Tabas I. Chapter 22 Lipids and atherosclerosis New Comprehensive Biochemistry. 36: 573-597. DOI: 10.1016/S0167-7306(02)36024-1  0.445
2001 Leventhal AR, Chen W, Tall AR, Tabas I. Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux. The Journal of Biological Chemistry. 276: 44976-83. PMID 11579092 DOI: 10.1074/Jbc.M106455200  0.792
2001 Chen W, Sun Y, Welch C, Gorelik A, Leventhal AR, Tabas I, Tall AR. Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes. The Journal of Biological Chemistry. 276: 43564-9. PMID 11559713 DOI: 10.1074/Jbc.M107938200  0.785
2001 Yao PM, Tabas I. Free Cholesterol Loading of Macrophages Is Associated with Widespread Mitochondrial Dysfunction and Activation of the Mitochondrial Apoptosis Pathway Journal of Biological Chemistry. 276: 42468-42476. PMID 11533046 DOI: 10.1074/Jbc.M101419200  0.392
2001 Sakr SW, Eddy RJ, Barth H, Wang F, Greenberg S, Maxfield FR, Tabas I. The uptake and degradation of matrix-bound lipoproteins by macrophages require an intact actin Cytoskeleton, Rho family GTPases, and myosin ATPase activity. The Journal of Biological Chemistry. 276: 37649-58. PMID 11477084 DOI: 10.1074/Jbc.M105129200  0.319
2001 Tabas I. p53 and atherosclerosis Circulation Research. 88: 747-749. PMID 11325863 DOI: 10.1161/Hh0801.090536  0.489
2000 Marathe S, Choi Y, Leventhal AR, Tabas I. Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation. Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 2607-13. PMID 11116060 DOI: 10.1161/01.Atv.20.12.2607  0.771
2000 Tabas I. Cholesterol and phospholipid metabolism in macrophages Biochimica Et Biophysica Acta - Molecular and Cell Biology of Lipids. 1529: 164-174. PMID 11111086 DOI: 10.1016/S1388-1981(00)00146-3  0.497
2000 Zhang D, Tang W, Yao PM, Yang C, Xie B, Jackowski S, Tabas I. Macrophages deficient in CTP: Phospnocholine cytidylyltransferase-α are viable under normal culture conditions but are highly susceptible to free cholesterol-induced death: Molecular genetic evidence that the induction of phosphatidylcholine biosynthesis in free cholesterol-loaded macrophages is an adaptive response Journal of Biological Chemistry. 275: 35368-35376. PMID 10944538 DOI: 10.1074/jbc.M007099200  0.319
2000 Marathe S, Miranda SR, Devlin C, Johns A, Kuriakose G, Williams KJ, Schuchman EH, Tabas I. Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: relationship between brain intra-lysosomal enzyme activity and central nervous system function. Human Molecular Genetics. 9: 1967-76. PMID 10942425 DOI: 10.1093/Hmg/9.13.1967  0.305
2000 Khelef N, Soe TT, Quehenberger O, Beatini N, Tabas I, Maxfield FR. Enrichment of acyl coenzyme A:cholesterol O-acyltransferase near trans-golgi network and endocytic recycling compartment. Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 1769-76. PMID 10894815 DOI: 10.1161/01.Atv.20.7.1769  0.385
2000 Wong ML, Xie B, Beatini N, Phu P, Marathe S, Johns A, Gold PW, Hirsch E, Williams KJ, Licinio J, Tabas I. Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis. Proceedings of the National Academy of Sciences of the United States of America. 97: 8681-6. PMID 10890909 DOI: 10.1073/Pnas.150098097  0.363
2000 Yao PM, Tabas I. Free cholesterol loading of macrophages induces apoptosis involving the Fas pathway Journal of Biological Chemistry. 275: 23807-23813. PMID 10791964 DOI: 10.1074/Jbc.M002087200  0.443
1999 Marathe S, Kuriakose G, Williams KJ, Tabas I. Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix Arteriosclerosis, Thrombosis, and Vascular Biology. 19: 2648-2658. PMID 10559007 DOI: 10.1161/01.Atv.19.11.2648  0.391
1999 Buton X, Mamdouh Z, Ghosh R, Du H, Kuriakose G, Beatini N, Grabowski GA, Maxfield FR, Tabas I. Unique cellular events occurring during the initial interaction of macrophages with matrix-retained or methylated aggregated low density lipoprotein (LDL). Prolonged cell-surface contact during which ldl-cholesteryl ester hydrolysis exceeds ldl protein degradation. The Journal of Biological Chemistry. 274: 32112-21. PMID 10542246 DOI: 10.1074/Jbc.274.45.32112  0.451
1999 Tabas I. Nonoxidative modifications of lipoproteins in atherogenesis Annual Review of Nutrition. 19: 123-139. PMID 10448519 DOI: 10.1146/Annurev.Nutr.19.1.123  0.459
1998 Williams KJ, Tabas I. The response-to-retention hypothesis of atherogenesis reinforced Current Opinion in Lipidology. 9: 471-474. PMID 9812202 DOI: 10.1097/00041433-199810000-00012  0.398
1998 Mukherjee S, Zha X, Tabas I, Maxfield FR. Cholesterol distribution in living cells: fluorescence imaging using dehydroergosterol as a fluorescent cholesterol analog. Biophysical Journal. 75: 1915-25. PMID 9746532 DOI: 10.1016/S0006-3495(98)77632-5  0.417
1998 Khelef N, Buton X, Beatini N, Wang H, Meiner V, Chang TY, Farese RV, Maxfield FR, Tabas I. Immunolocalization of acyl-coenzyme A:cholesterol O-acyltransferase in macrophages. The Journal of Biological Chemistry. 273: 11218-24. PMID 9556612 DOI: 10.1074/Jbc.273.18.11218  0.333
1998 Jeong Ts, Schissel SL, Tabas I, Pownall HJ, Tall AR, Jiang X. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. The Journal of Clinical Investigation. 101: 905-12. PMID 9466986 DOI: 10.1172/Jci870  0.57
1998 Marathe S, Schissel SL, Yellin MJ, Beatini N, Mintzer R, Williams KJ, Tabas I. Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling Journal of Biological Chemistry. 273: 4081-4088. PMID 9461601 DOI: 10.1074/Jbc.273.7.4081  0.372
1998 Zha X, Pierini LM, Leopold PL, Skiba PJ, Tabas I, Maxfield FR. Sphingomyelinase treatment induces ATP-independent endocytosis. The Journal of Cell Biology. 140: 39-47. PMID 9425152 DOI: 10.1083/Jcb.140.1.39  0.32
1997 Tabas I. Phospholipid metabolism in cholesterol-loaded macrophages Current Opinion in Lipidology. 8: 263-267. PMID 9335949 DOI: 10.1097/00041433-199710000-00004  0.489
1997 Zha X, Tabas I, Leopold PL, Jones NL, Maxfield FR. Evidence for prolonged cell-surface contact of acetyl-LDL before entry into macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology. 17: 1421-31. PMID 9261276 DOI: 10.1161/01.Atv.17.7.1421  0.46
1997 Tabas I. Free cholesterol-induced cytotoxicity: A possible contributing factor to macrophage foam cell necrosis in advanced atherosclerotic lesions Trends in Cardiovascular Medicine. 7: 256-263. DOI: 10.1016/S1050-1738(97)00086-8  0.452
1996 Keesler GA, Gabel BR, Devlin CM, Koschinsky ML, Tabas I. The binding activity of the macrophage lipoprotein(a)/apolipoprotein(a) receptor is induced by cholesterol via a post-translational mechanism and recognizes distinct kringle domains on apolipoprotein(a). The Journal of Biological Chemistry. 271: 32096-104. PMID 8943262 DOI: 10.1074/Jbc.271.50.32096  0.42
1996 Schissel SL, Tweedie-Hardman J, Rapp JH, Graham G, Williams KJ, Tabas I. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein: Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins Journal of Clinical Investigation. 98: 1455-1464. PMID 8823312  0.317
1996 Tabas I, Marathe S, Keesler GA, Beatini N, Shiratori Y. Evidence that the initial up-regulation of phosphatidylcholine biosynthesis in free cholesterol-loaded macrophages is an adaptive response that prevents cholesterol-induced cellular necrosis. Proposed role of an eventual failure of this response in foam cell necrosis in advanced atherosclerosis Journal of Biological Chemistry. 271: 22773-22781. PMID 8798453 DOI: 10.1074/Jbc.271.37.22773  0.476
1996 Schissel SL, Schuchman EH, Williams KJ, Tabas I. Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene Journal of Biological Chemistry. 271: 18431-18436. PMID 8702487 DOI: 10.1074/Jbc.271.31.18431  0.369
1996 Skiba PJ, Zha X, Maxfield FR, Schissel SL, Tabas I. The distal pathway of lipoprotein-induced cholesterol esterification, but not sphingomyelinase-induced cholesterol esterification, is energy-dependent. The Journal of Biological Chemistry. 271: 13392-400. PMID 8662777 DOI: 10.1074/Jbc.271.23.13392  0.435
1996 Wang N, Tabas I, Winchester R, Ravalli S, Rabbani LE, Tall A. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. The Journal of Biological Chemistry. 271: 8837-42. PMID 8621523 DOI: 10.1074/Jbc.271.15.8837  0.531
1995 Shiratori Y, Houweling M, Zha X, Tabas I. Stimulation of CTP:phosphocholine cytidylyltransferase by free cholesterol loading of macrophages involves signaling through protein dephosphorylation Journal of Biological Chemistry. 270: 29894-29903. PMID 8530387 DOI: 10.1074/Jbc.270.50.29894  0.316
1995 Tabas I. The stimulation of the cholesterol esterification pathway by atherogenic lipoproteins in macrophages Current Opinion in Lipidology. 6: 260-268. PMID 8520847 DOI: 10.1097/00041433-199510000-00004  0.488
1995 Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis Arteriosclerosis, Thrombosis, and Vascular Biology. 15: 551-562. PMID 7749869 DOI: 10.1161/01.Atv.15.5.551  0.37
1995 Schissel SL, Beatini N, Zha X, Maxfield FR, Tabas I. Effect and cellular site of action of cysteine protease inhibitors on the cholesterol esterification pathway in macrophages and Chinese hamster ovary cells. Biochemistry. 34: 10463-73. PMID 7654700 DOI: 10.1021/Bi00033A019  0.461
1994 Shiratori Y, Okwu AK, Tabas I. Free cholesterol loading of macrophages stimulates phosphatidylcholine biosynthesis and up-regulation of CTP:phosphocholine cytidylyltransferase Journal of Biological Chemistry. 269: 11337-11348. PMID 8157665  0.309
1994 Tabas I, Zha X, Beatini N, Myers JN, Maxfield FR. The actin cytoskeleton is important for the stimulation of cholesterol esterification by atherogenic lipoproteins in macrophages. The Journal of Biological Chemistry. 269: 22547-56. PMID 8077203  0.358
1994 Keesler GA, Li Y, Skiba PJ, Fless GM, Tabas I. Macrophage foam cell lipoprotein(a)/apoprotein(a) receptor: Cell-surface localization, dependence of induction on new protein synthesis, and ligand specificity Arteriosclerosis, Thrombosis, and Vascular Biology. 14: 1337-1345. PMID 8049196 DOI: 10.1161/01.Atv.14.8.1337  0.415
1994 Okwu AK, Xu XX, Shiratori Y, Tabas I. Regulation of the threshold for lipoprotein-induced acyl-CoA:cholesterol O-acyltransferase stimulation in macrophages by cellular sphingomyelin content Journal of Lipid Research. 35: 644-655. PMID 8006519  0.383
1994 Tabas I. Atherosclerosis Current Opinion in Lipidology. 5: U126-130. DOI: 10.1097/00041433-199410000-00017  0.408
1993 Bottalico LA, Keesler GA, Fless GM, Tabas I. Cholesterol loading of macrophages leads to marked enhancement of native lipoprotein(a) and apoprotein(a) internalization and degradation Journal of Biological Chemistry. 268: 8569-8573. PMID 8473302  0.358
1993 Bottalico LA, Kendrick NC, Keller A, Li Y, Tabas I. Cholesteryl ester loading of mouse peritoneal macrophages is associated with changes in the expression or modification of specific cellular proteins, including increase in an α-enolase isoform Arteriosclerosis, Thrombosis, and Vascular Biology. 13: 264-275. PMID 8427861 DOI: 10.1161/01.Atv.13.2.264  0.392
1993 Myers JN, Tabas I, Jones NL, Maxfield FR. Beta-very low density lipoprotein is sequestered in surface-connected tubules in mouse peritoneal macrophages. The Journal of Cell Biology. 123: 1389-402. PMID 8253839 DOI: 10.1083/Jcb.123.6.1389  0.333
1991 Xu XX, Tabas I. Lipoproteins activate acyl-coenzyme A:Cholesterol acyltransferase in macrophages only after cellular cholesterol pools are expanded to a critical threshold level Journal of Biological Chemistry. 266: 17040-17048. PMID 1894601  0.357
1991 Xu XX, Tabas I. Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages Journal of Biological Chemistry. 266: 24849-24858. PMID 1761578  0.39
1991 Tabas I, Myers JN, Innerarity TL, Xu XX, Arnold K, Boyles J, Maxfield FR. The influence of particle size and multiple apoprotein E-receptor interactions on the endocytic targeting of beta-VLDL in mouse peritoneal macrophages. The Journal of Cell Biology. 115: 1547-60. PMID 1661729 DOI: 10.1083/Jcb.115.6.1547  0.324
1990 Tabas I, Lim S, Xu XX, Maxfield FR. Endocytosed beta-VLDL and LDL are delivered to different intracellular vesicles in mouse peritoneal macrophages. The Journal of Cell Biology. 111: 929-40. PMID 2391369 DOI: 10.1083/Jcb.111.3.929  0.375
1989 Khoo JC, Miller E, McLoughlin P, Tabas I, Rosoff WJ. Cholesterol esterification as a limiting factor in accumulation of cell cholesterol: a comparison of two J774 macrophage cell lines. Biochimica Et Biophysica Acta. 1012: 215-7. PMID 2742881 DOI: 10.1016/0167-4889(89)90099-2  0.419
1989 Tabas I, Feinmark SJ, Beatini N. The reactivity of desmosterol and other shellfish- and xanthomatosis-associated sterols in the macrophage sterol esterification reaction Journal of Clinical Investigation. 84: 1713-1721. PMID 2592557 DOI: 10.1172/Jci114354  0.459
1988 Tabas I, Rosoff WJ, Boykow GC. Acyl coenzyme A:cholesterol acyl transferase in macrophages utilizes a cellular pool of cholesterol oxidase-accessible cholesterol as substrate. The Journal of Biological Chemistry. 263: 1266-72. PMID 3422077  0.362
1987 Tabas I, Boykow GC, Tall AR. Foam cell-forming J774 macrophages have markedly elevated acyl coenzyme A:cholesterol acyl transferase activity compared with mouse peritoneal macrophages in the presence of low density lipoprotein (LDL) despite similar LDL receptor activity. The Journal of Clinical Investigation. 79: 418-26. PMID 3805276 DOI: 10.1172/Jci112828  0.636
1987 Tabas I, Boykow GC. Protein synthesis inhibition in mouse peritoneal macrophages results in increased acyl coenzyme A:cholesterol acyl transferase activity and cholesteryl ester accumulation in the presence of native low density lipoprotein Journal of Biological Chemistry. 262: 12175-12181. PMID 3624250  0.412
1987 Tall A, Granot E, Brocia R, Tabas I, Hesler C, Williams K, Denke M. Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. The Journal of Clinical Investigation. 79: 1217-25. PMID 3558822 DOI: 10.1172/Jci112940  0.519
1987 Granot E, Tabas I, Tall AR. Human plasma cholesteryl ester transfer protein enhances the transfer of cholesteryl ester from high density lipoproteins into cultured HepG2 cells. The Journal of Biological Chemistry. 262: 3482-7. PMID 3029115  0.525
1986 Tabas I, Weiland DA, Tall AR. Inhibition of acyl coenzyme A:cholesterol acyl transferase in J774 macrophages enhances down-regulation of the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase and prevents low density lipoprotein-induced cholesterol accumulation. The Journal of Biological Chemistry. 261: 3147-55. PMID 3949765  0.573
1986 Tall AR, Tabas I, Williams KJ. Lipoprotein-liposome interactions. Methods in Enzymology. 128: 647-57. PMID 3724528 DOI: 10.1016/0076-6879(86)28097-0  0.544
1986 Williams KJ, Tall AR, Tabas I, Blum C. Recognition of vesicular lipoproteins by the apolipoprotein B,E receptor of cultured fibroblasts. Journal of Lipid Research. 27: 892-900. PMID 3021887  0.505
1985 Tabas I, Weiland DA, Tall AR. Unmodified low density lipoprotein causes cholesteryl ester accumulation in J774 macrophages. Proceedings of the National Academy of Sciences of the United States of America. 82: 416-20. PMID 3855559 DOI: 10.1073/Pnas.82.2.416  0.617
1984 Tabas I, Tall AR. Mechanism of the association of HDL3 with endothelial cells, smooth muscle cells, and fibroblasts. Evidence against the role of specific ligand and receptor proteins. The Journal of Biological Chemistry. 259: 13897-905. PMID 6438086  0.326
1983 Varki AP, Reitman ML, Tabas I, Kornfeld S. Studies of the synthesis, structure and function of the phosphorylated oligosaccharides of lysosomal enzymes Journal of Biosciences. 5: 101-104. DOI: 10.1007/Bf02702980  0.564
1982 Tabas I, Kornfeld S. N-asparagine-linked oligosaccharides: processing. Methods in Enzymology. 83: 416-29. PMID 7098944 DOI: 10.1016/0076-6879(82)83039-5  0.51
1982 Tabas I, Kornfeld S. [37] N-asparagine-linked oligosaccharides: Processing Methods in Enzymology. 83: 416-429. DOI: 10.1016/0076-6879(82)83039-5  0.417
1981 Kornfeld S, Tabas I, Varki A, Reitman M. STEPS IN THE FORMATION OF ASPARAGINE-LINKED CARBOHYDRATE MOIETIES Biochemical Society Transactions. 9: 11P-11P. DOI: 10.1042/Bst009011P  0.564
1978 Tabas I, Schlesinger S, Kornfeld S. Processing of high mannose oligosaccharides to form complex type oligosaccharides on the newly synthesized polypeptides of the vesicular stomatitis virus G protein and the IgG heavy chain Journal of Biological Chemistry. 253: 716-722. PMID 202596  0.429
Show low-probability matches.